Most Recent

image: The Psychiatrist’s Jigsaw

The Psychiatrist’s Jigsaw

By | November 1, 2013

Researchers are piecing together the devilishly complex sets of genetic alterations underlying schizophrenia and bipolar disorder.

4 Comments

image: Going Viral

Going Viral

By | September 1, 2013

From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.

6 Comments

image: Engineering Life

Engineering Life

By , , and | August 1, 2013

Cellular “tinkering” is critical for establishing a new engineering discipline that will lead to the next generation of technologies based on life’s building blocks.

3 Comments

image: Models of Transparency

Models of Transparency

By , , , and | April 1, 2013

Researchers are taking advantage of small, transparent zebrafish embryos and larvae—and a special strain of see-through adults—to understand the development and spread of cancer.

0 Comments

image: Lamarck and the Missing Lnc

Lamarck and the Missing Lnc

By | October 1, 2012

Epigenetic changes accrued over an organism’s lifetime may leave a permanent heritable mark on the genome, through the help of long noncoding RNAs.

21 Comments

image: Best Places to Work Academia, 2012

Best Places to Work Academia, 2012

By | August 1, 2012

On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.

0 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Targeting DNA

Targeting DNA

By | June 1, 2012

After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.

13 Comments

image: Underground Supermodels

Underground Supermodels

By | June 1, 2012

What can a twentysomething naked mole-rat tell us about fighting pain, cancer, and aging?

12 Comments

image: Freezing Time

Freezing Time

By | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham